WJ Groh, AJ Moss, EL Logigian… - Neurology, 2011 - AAN Enterprises Reply from the Authors: We thank Misra et al. for their interest but they may have misunderstood the main objective of our study: to evaluate the short- term efficacy of a previously untested drug, pregaba- lin, in RLS. The only way to perform a proof-of-concept study is to use ... Related articles - All 3 versions
DLR Rayan, E Matthews, G Barreto, SV Tan… - 2011 - discovery.ucl.ac.uk ... Assessing the efficacy of Mexiletine in UK patients with non-dystrophic myotonia. ... Type: Proceedings paper. Title: Assessing the efficacy of Mexiletine in UK patients with non-dystrophic myotonia. Event: United Kingdom Neuromuscular Translational Research Conference 2011. ... Cached
C Zheng, D Zhang, Q Wu… - Chirality, 2011 - Wiley Online Library A series of novel designed mexiletine derivatives and its analogs were prepared, the structures were confirmed by Nuclear Magnetic Resonance (NMR), Fourier Transform Infrared Spectroscopy (FTIR), and Electrospray Ionization-Mass Spectrometry (ESI-MS), and the ... Related articles - All 2 versions
[CITATION] P28 Assessing the efficacy of Mexiletine in UK patients with non-dystrophic myotonia
DL Rayan, E Matthews, G Barreto, SV Tan… - Neuromuscular …, 2011 - Elsevier
UK Misra, J Kalita, B Kumar, S Prasad… - Neurology, 2011 - AAN Enterprises ...MEXILETINE IS AN EFFECTIVE ANTIMYOTONIA TREATMENT IN MYOTONIC DYSTROPHY TYPE 1 To the Editor: Logigian et al.1 conclude that mexil- etine is safe and effective for the treatment of myoto- nia in patients with myotonic dystrophy type 1 (DM1). ... Related articles - All 3 versions